FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
(Updated - March 16, 2022 6:16 AM EDT)
Cowen analyst Shaul Eyal lowered the price target on SentinelOne Inc (NYSE: S) to $65.00 (from $77.00) while maintaining a Outperform rating.
The analyst comments "S reported strong F4Q22 results, with revenue up 120% y/y and... More
Barclays analyst Kannan Venkateshwar lowered the price target on SentinelOne Inc (NYSE: S) to $37.00 (from $39.00) while maintaining a Overweight rating.... More
(Updated - March 16, 2022 6:16 AM EDT)
BofA Securities analyst Tai Liani lowered the price target on SentinelOne Inc (NYSE: S) to $54.00 (from $67.00) while maintaining a Buy rating.
The analyst comments "While SentinelOne is still in the early innings, we see strong... More
(Updated - March 16, 2022 6:18 AM EDT)
Wolfe Research analyst Joshua Tilton lowered the price target on SentinelOne Inc (NYSE: S) to $38.00 (from $52.00) while maintaining a Outperform rating.
The analyst comments "SentinelOne reported 4Q results that were ahead of consensus across key... More
UBS analyst Roger Boyd lowered the price target on SentinelOne Inc (NYSE: S) to $56.00 (from $75.00) while maintaining a Neutral rating.... More
After-Hours Stock Movers:
Catalyst Biosciences, Inc. (NASDAQ: CBIO) 18% HIGHER; announced that the company has regained full rights to CB 2782-PEG, a C3-degrader for the treatment of dry AMD (dAMD). Under the terms of the agreement, Biogen has returned the rights for further development on CB 2782-PEG and has ended the collaboration on other potential AMD treatments.
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) 12.6% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has allowed an... More
SentinelOne, Inc. (NYSE: S) shares were trading around 6% lower after-hours despite a Q4 beat and better than expected guidance.
EPS for the fourth quarter came in at ($0.17), slightly better than the consensus estimate of ($0.18). Revenue grew 120% year-over-year to $65.6 million, compared to the consensus estimate of... More
SentinelOne, Inc. (NYSE: S) reported Q4 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $65.6 million versus the consensus estimate of $60.65 million.
GUIDANCE:
SentinelOne, Inc. sees Q1 2023 revenue of $74-75 million, versus the consensus of... More
SentinelOne (NYSE: S), an autonomous cybersecurity platform company, today announced it has entered into a definitive agreement to acquire... More
